A4 HIV/STD Co-Infection: Epidemiology

Tuesday, March 9, 2010: 10:15 AM-12:00 PM
International Ballroom A/B/C/D (M2) (Omni Hotel)
Moderator:
10:15 AM
A4a
Gender and Age Patterns in HSV-2 and HIV Among Non-Injecting Drug Users
Don Des Jarlais, PhD1, Kamyar Arasteh, PhD1, Courtney McKnight, MPH1, David Perlman, MD2, Holly Hagan, PhD3, Salaam Semaan, DrPH4 and Samuel Friedman, PhD5, 1Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY, 2Department of Medicine, Beth Israel Medical Center, New York, NY, 3College of Nursing, New York University, New York, NY, 4National Center for HIV/AIDS, viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 5AIDS Research, National Development and Research Institutes, Inc, New York, NY
10:30 AM
A4b
Factors Associated with HIV Seroconversion Among Men Diagnosed with Gonorrhea in Washington State: An Evidence Base for Targeting Integrated Partner Services
Mark Stenger, MA, Infectious Disease & Reproductive Health, Assessment Unit, Washington State Department of Health, Olympia, WA, Roxanne Kerani, PhD, STD Control Program, Public Health - Seattle and King County, Seattle, WA, Matthew Golden, MPH, MD, Center for AIDS and STD, University of Washington, Seattle, WA and Mark Aubin, BA, STD Services Section, Washington State Department of Health, Olympia, WA
10:45 AM
A4c
Defining and Describing HIV and STD Core Group Membership Using Population-Based Surveillance Data
Patsy Lloyd, BS, ScM, Department of Epidemiology and Biostatistics, The George Washington University, Washington, DC, Preeti Pathela, DrPH, MPH, Bureau of Sexually Transmitted Disease Control, The New York Department of Health and Mental Hygiene, New York, NY and Julia Schillinger, MD, MSc, Bureau of Sexually Transmitted Disease Control, NYC DOHMH / Division of Sexually Transmitted Disease Prevention, The Centers for Disease Control and Prevention, New York, NY
11:00 AM
A4d
STD Co-Infection Among HIV-Positive Baltimore City Residents, 2004-2008
John Christian Hague, MPH, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, Ravikiran Muvva, MPH, MPA, MBBS, Bureau of HIV/STD Prevention, Johns Hopkins School of Medicine, Baltimore City Health Department, Baltimore, MD and Rafiq Miazad, MD, MPH, STD Prevention Program, Baltimore City Health Department, Baltimore, MD
11:15 AM
A4e
Improving Sexually Transmitted Disease (STD) Clinic Based HIV Partner Services: Checking the HIV/AIDS Registry (HARS) for Named Partners in 9 New York City Publicly Funded STD Clinics
Alexis V. Kowalski, MPH1, Elizabeth Begier, MD, MPH2, Kathy Middleton, MPH3, Tamar Renaud, MPH4, Rose Gasner, JD5, Steven R. Rubin6 and Susan Blank, MD, MPH6, 1Bureau of STD Control, NYC Department of health & Mental Hygiene, New York, NY, 2Division of Vital Statistics, NYC Department of Health and Mental Hygiene, Manhattan, NY, 3STD Control, NYC DOHMH, Manhattan, NY, 4Bureau of HIV/AIDS Prevention and Control, NYC Department of Health and Mental Hygiene, Manhattan, NY, 5Division of Disease Control, NYC DOHMH, New York, NY, 6Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY
11:30 AM
A4f
HIV/AIDS and STD Co-Morbidity Assessment with the Use of Case-Based Registry Matching, California, 2007
Jennifer Brodsky, MPH1, Michael Samuel, DrPH2, Mark Damesyn, DrPH3, Peter Kerndt, MD, MPH4, Kyle Bernstein, PhD, ScM5 and Gail Bolan, MD1, 1Sexually Transmitted Disease Control Branch, California Department of Public Health, Richmond, CA, 2Epidemiology and Surveillance Section, California Department of Public Health, STD Control Branch, Richmond, CA, 3Office of AIDS, California Department of Public Health, Sacramento, CA, 4STD Program, Los Angeles County Department of Public Health, Los Angeles, CA, 5STD Prevention and Control Services Program, San Francisco Department of Public Health, San Francisco, CA
See more of: Oral and Poster